Cargando…
The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy
PD-1 blockade rescues failing anticancer immune responses, resulting in durable remissions in some cancer patients. Cytokines such as IFNγ and IL-2 contribute to the anti-tumor effect of PD-1 blockade. IL-9 was identified over the last decade as a cytokine demonstrating a potent ability to harness t...
Autores principales: | Vinokurova, Daria, Apetoh, Lionel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136177/ https://www.ncbi.nlm.nih.gov/pubmed/37189417 http://dx.doi.org/10.3390/biom13040670 |
Ejemplares similares
-
Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells
por: Apetoh, Lionel
Publicado: (2020) -
T(H)9 cells in anti-tumor immunity
por: Rivera Vargas, Thaiz, et al.
Publicado: (2016) -
Emerging targets for anticancer vaccination: PD-1
por: Tobias, J., et al.
Publicado: (2021) -
The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
por: Sui, Xinbing, et al.
Publicado: (2015) -
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
por: Sakuishi, Kaori, et al.
Publicado: (2011)